Pathogenic variants in the PLS3 gene, located on the X chromosome, have been linked to skeletal fragility in hemizygous males, whereas heterozygous females may exhibit a range of clinical phenotypes, from normal bone mineral density with no fractures to early-onset osteoporosis. This evidence concerns the gene PLS3 and osteoporosis.